Skip to content

A Phase 3b Open-Label Study of Long-Term Neurocognitive Outcomes in Children With Phenylketonuria Treated With Sepiapterin

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-514435-20-00
Acronym
PTC923-PKU-401
Enrollment
60
Registered
2025-07-14
Start date
2025-12-23
Completion date
Unknown
Last updated
2025-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phenylketonuria

Brief summary

Mean change in full-scale intelligence quotient (FSIQ) (WPPSI-IV or WISC-V) over a 2-year period: WPPSI-IV (Wechsler Preschool and Primary Scale of Intelligence - Fourth Edition): for participants ≥30 months to <6 years of age, WISC-V (Wechsler Intelligence Scale for Children - Fifth Edition): for participants ≥6 years to 16 years of age

Detailed description

01. Change from baseline in phenylketonuriaquality of life (PKU-QOL) questionnaire score over time, 02. Change from baseline in European Quality of Life - 5 Dimensions (EQ-5D) score over time, 03. Mean change in FSIQ (WPPSI-IV or WISC-V) over a 4-year period, 04. Change of phenylalanine (Phe) levels over time

Interventions

DRUGPTC923

Sponsors

PTC Therapeutics Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
0 Years to 17 Years

Design outcomes

Secondary

MeasureTime frame
01. Change from baseline in phenylketonuriaquality of life (PKU-QOL) questionnaire score over time, 02. Change from baseline in European Quality of Life - 5 Dimensions (EQ-5D) score over time, 03. Mean change in FSIQ (WPPSI-IV or WISC-V) over a 4-year period, 04. Change of phenylalanine (Phe) levels over time

Primary

MeasureTime frame
Mean change in full-scale intelligence quotient (FSIQ) (WPPSI-IV or WISC-V) over a 2-year period: WPPSI-IV (Wechsler Preschool and Primary Scale of Intelligence - Fourth Edition): for participants ≥30 months to <6 years of age, WISC-V (Wechsler Intelligence Scale for Children - Fifth Edition): for participants ≥6 years to 16 years of age

Countries

France, Ireland, Poland, Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026